Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 19-OCT-2025, the patient received the 2nd dose of Shingles vaccine. In OCT-2025, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: Sick). Rechallenge with Shingles vaccine was positive. The outcome of the sickness was not reported. The reporter considered the sickness to be related to Shingles vaccine. The company considered the sickness to be related to Shingles vaccine. Linked case(s) involving the same patient: US2025AMR143469 Additional Information: GSK Receipt Date: 22-OCT-2025 This case was reported by a patient via interactive digital media. Patient got Shingles vaccine and both time patient felt sick. For tolerance of 1st dose of Shingles vaccine, refer case US2025AMR143469.; Sender's Comments: US-GSK-US2025AMR143469:Same patient (First dose)